Crinetics Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Crinetics Pharmaceuticals Inc
TickerCRNX
CIK #0001658247
CUSIP22663K107
SectorLife Sciences - Pharmaceutical Preparations
Address10222 Barnes Canyon Road, Bldg #2, San Diego, CA 92121
Source [EDGAR]
CIK Filing 2011 - 2024
[0001658247] 10-K
[0001658247] 10-Q
[0001658247] 3
[0001658247] 4
[0001658247] 5
[0001658247] 8-K
[0001658247] D
[0001658247] SC 13D
[0001658247] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Braidwell LP Crinetics Pharmaceuticals Inc [2023-02-14] 6.45
Wellington Management Group LLP Crinetics Pharmaceuticals Inc [2023-02-06] 5.21
Driehaus Capital Management LLC Crinetics Pharmaceuticals Inc [2022-01-10] 10.09
Biotechnology Value Fund L P Crinetics Pharmaceuticals Inc [2021-10-29] 3.5
Deep Track Capital LP Crinetics Pharmaceuticals Inc [2021-04-22] 5.05
BlackRock Inc Crinetics Pharmaceuticals Inc [2021-02-02] 6.4
OrbiMed Advisors LLC Crinetics Pharmaceuticals Inc [2020-02-14] 8.42
Struthers Richard Scott Crinetics Pharmaceuticals Inc [2020-02-11] 6.1
Versant Venture Capital V LP Crinetics Pharmaceuticals Inc [2019-02-14] 12.4
RA Capital Management LLC Crinetics Pharmaceuticals Inc [2019-02-14] 7.8
FMR LLC Crinetics Pharmaceuticals Inc [2018-09-10] 0.0
Perceptive Advisors LLC Crinetics Pharmaceuticals Inc [2018-07-30] 0.9
5AM Ventures IV LP Crinetics Pharmaceuticals Inc [2018-07-30] 14.6
OrbiMed Advisors LLC Crinetics Pharmaceuticals Inc [2018-07-30] 8.01
Vivo Capital VIII LLC Crinetics Pharmaceuticals Inc [2018-07-26] 14.4
Form 3/4/5 Filer 2011 - 2024
Crinetics Pharmaceuticals, Inc.
Vivaldi Coelho Rogerio
Pizzuti Dana
Struthers Richard Scott
Krasner Alan Seth
Knight Jeff E.
Wilson Marc
Betz Stephen F.
Hassard James
Fust Matthew K
Bedrosian Camille L
Deardorf Caren
Wierenga Wendall
Okey Stephanie
Nichols Weston
Perceptive Life Sciences Master Fund Ltd
Edelman Joseph
Perceptive Advisors LLC
Madan Ajay
Kaldor Stephen W
Vivo Capital Surplus Fund VIII, L.P.
Vivo Capital Fund VIII, L.P.
Vivo Capital VIII, LLC
Vivo Opportunity, LLC
Vivo Opportunity Fund, L.P.
Schwab Andrew J.
Rocklage Scott M
5AM Ventures IV, L.P.
Diekman John D
5AM Partners IV, LLC
5AM Co-Investors IV, L.P.
Nielsen Jack
Versant Venture Capital V (Canada), LP
Versant Ophthalmic Affiliates I, L.P.
Versant Venture Capital V, L.P.
Versant Ventures V, LLC
Versant Affiliates Fund V, L.P.
Versant Ventures V (Canada), L.P.
Vivo Capital, LLC
OrbiMed Capital GP VI LLC
OrbiMed Advisors LLC
Freeman Mason
Form 13F Holdings
Firm Period DFND Voting Shares
Driehaus Capital Management LLC [2023-03-31] SOLE 4,827,650.0 5,289,519.0
BlackRock Inc. [2023-03-31] SOLE 3,859,304.0 3,956,358.0
OrbiMed Advisors LLC [2023-03-31] DFND 3,196,876.0 3,950,796.0
Wellington Management Group LLP [2023-03-31] DFND 0.0 3,635,526.0
Perceptive Advisors LLC [2023-03-31] SOLE 3,554,887.0 3,554,887.0
BVF Inc/IL [2023-03-31] DFND 0.0 2,736,613.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 2,618,824.0
Bain Capital Life Sciences Investors, LLC [2023-03-31] SOLE 2,305,558.0 2,305,558.0
State Street Corp [2023-03-31] DFND 2,120,624.0 2,218,794.0
Braidwell LP [2023-03-31] SOLE 2,019,714.0 2,019,714.0
First Light Asset Management LLC [2023-03-31] SOLE 1,619,125.0 1,619,125.0
Frazier Life Sciences Management LP [2023-03-31] SOLE 1,414,823.0 1,414,823.0
EcoR1 Capital LLC [2023-03-31] SOLE 1,330,263.0 1,330,263.0
Paradigm Biocapital Advisors LP [2023-03-31] SOLE 1,133,782.0 1,133,782.0
Novo Holdings A/S [2023-03-31] SOLE 1,100,000.0 1,100,000.0
Geode Capital Management LLC [2023-03-31] DFND 954,860.0 954,860.0
T. Rowe Price Investment Management, Inc. [2023-03-31] SOLE 275,694.0 929,369.0
FMR LLC [2023-03-31] DFND 919,632.0 920,958.0
Finepoint Capital LP [2023-03-31] SOLE 868,427.0 868,427.0
5AM Venture Management LLC [2023-03-31] SOLE 862,286.0 862,286.0
Opaleye Management Inc [2023-03-31] SOLE 785,794.0 785,794.0
Saturn V Capital Management LLC [2023-03-31] SOLE 741,043.0 741,043.0
BNP Paribas Asset Management Holding S.A. [2023-03-31] DFND 0.0 691,201.0
Morgan Stanley [2023-03-31] DFND 647,500.0 652,916.0
GW&K Investment Management LLC [2023-03-31] SOLE 536,880.0 536,880.0
Goldman Sachs Group Inc [2023-03-31] DFND 520,168.0 520,198.0
Northern Trust Corp [2023-03-31] DFND 21,282.0 477,018.0
Eventide Asset Management LLC [2023-03-31] SOLE 434,768.0 434,768.0
Walleye Capital LLC [2023-03-31] SOLE 433,695.0 433,695.0
Bank of New York Mellon Corp [2023-03-31] DFND 375,389.0 416,457.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com